Peng-Ju Ye

Cell Membrane-camouflaged Nanoparticles as Drug Carriers for Cancer Therapy.

D. He, Cuiyun Yu, Chengfei Xu, 2020, Acta biomaterialia.

Prolonged blood circulation outperforms active targeting for nanocarriers-mediated enhanced hepatocellular carcinoma therapy in vivo.

D. He, Cuiyun Yu, Peng-Ju Ye, 2022, Journal of controlled release : official journal of the Controlled Release Society.

Delivery of Liver-Specific miRNA-122 Using a Targeted Macromolecular Prodrug toward Synergistic Therapy for Hepatocellular Carcinoma.

Qian Ning, D. He, Cuiyun Yu, 2019, ACS applied materials & interfaces.

In vitro and in vivo evaluation of macromolecular prodrug GC-FUA based nanoparticle for hepatocellular carcinoma chemotherapy

Qian Ning, D. He, Cuiyun Yu, 2017, Drug delivery.

Facile fabrication of a novel hybrid nanoparticles by self-assembling based on pectin-doxorubicin conjugates for hepatocellular carcinoma therapy

D. He, Cuiyun Yu, Peng-Ju Ye, 2018, Artificial cells, nanomedicine, and biotechnology.

Fabrication and characterization of a novel self-assembling micelle based on chitosan cross-linked pectin–doxorubicin conjugates macromolecular pro-drug for targeted cancer therapy

D. He, Cuiyun Yu, Peng-Ju Ye, 2018, RSC advances.

Cell Membrane-Camouflaged Nanoparticles as Drug Carriers for Cancer Therapy

D. He, Cuiyun Yu, Chengfei Xu, 2019, SSRN Electronic Journal.